Form 4: Datadog CEO Olivier Pomel Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Datadog's CEO, Olivier Pomel, exercised stock options and sold Class A Common Stock under a pre-arranged 10b5-1 trading plan on February 10, 2025.
Summary
- On February 10, 2025, Olivier Pomel, the CEO of Datadog, Inc., engaged in transactions involving the company's stock.
- Pomel exercised stock options to acquire Class A Common Stock at prices of $0.3067 and $0.9092.
- He then sold shares of Class A Common Stock at weighted-average prices ranging from $144.6057 to $147.2309.
- These sales were executed under a 10b5-1 trading plan established on September 13, 2024.
- Following these transactions, Pomel directly owns 379,693 shares of Class A Common Stock and 8,532,885 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document primarily reports routine stock transactions under a pre-existing plan. No significant positive or negative implications are apparent.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating they were planned in advance and not based on insider information.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan mitigates this concern.
Future Outlook
The document does not contain specific forward-looking statements beyond the ongoing execution of the 10b5-1 trading plan.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units, which vest over time.
- Sales under 10b5-1 plans are a common mechanism for executives to diversify their holdings and manage personal finances.
- The size and frequency of these transactions are typical for executives at similarly sized technology companies.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price, but the 10b5-1 plan helps to mitigate any potential negative perception.
Key Dates
| Date | Description |
|---|---|
| 2024-09-13 | Date of 10b5-1 plan. |
| 2025-02-10 | Date of stock option exercise and stock sales. |
| 2025-02-12 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.